These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 30604283)

  • 1. Potential of GABA
    Maccioni P; Colombo G
    CNS Drugs; 2019 Feb; 33(2):107-123. PubMed ID: 30604283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [GABAB receptor as therapeutic target for drug addiction: from baclofen to positive allosteric modulators].
    Agabio R; Colombo G
    Psychiatr Pol; 2015; 49(2):215-23. PubMed ID: 26093587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive allosteric modulators of the GABAB receptor: a new class of ligands with therapeutic potential for alcohol use disorder.
    Colombo G
    Alcohol Alcohol; 2024 Mar; 59(3):. PubMed ID: 38566580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Advances in the Potential of Positive Allosteric Modulators of the GABAB Receptor to Treat Alcohol Use Disorder.
    Augier E
    Alcohol Alcohol; 2021 Feb; 56(2):139-148. PubMed ID: 33561865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The development of medications for alcohol-use disorders targeting the GABAB receptor system.
    Agabio R; Maccioni P; Carai MA; Gessa GL; Froestl W; Colombo G
    Recent Pat CNS Drug Discov; 2012 Aug; 7(2):113-28. PubMed ID: 22574677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppressing effect of CMPPE, a new positive allosteric modulator of the GABA
    Maccioni P; Fara F; Lorrai I; Acciaro C; Mugnaini C; Corelli F; Colombo G
    Alcohol; 2019 Mar; 75():79-87. PubMed ID: 30468987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of alcohol self-administration by positive allosteric modulators of the GABAB receptor in rats: lack of tolerance and potentiation of baclofen.
    Maccioni P; Vargiolu D; Thomas AW; Malherbe P; Mugnaini C; Corelli F; Leite-Morris KA; Gessa GL; Colombo G
    Psychopharmacology (Berl); 2015 May; 232(10):1831-41. PubMed ID: 25420609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GABA
    de Miguel E; Vekovischeva O; Kuokkanen K; Vesajoki M; Paasikoski N; Kaskinoro J; Myllymäki M; Lainiola M; Janhunen SK; Hyytiä P; Linden AM; Korpi ER
    Addict Biol; 2019 Nov; 24(6):1191-1203. PubMed ID: 30421860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and side effects of baclofen and the novel GABA
    Vengeliene V; Takahashi TT; Dravolina OA; Belozertseva I; Zvartau E; Bespalov AY; Spanagel R
    Psychopharmacology (Berl); 2018 Jul; 235(7):1955-1965. PubMed ID: 29651507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The GABA
    Augier E; Dulman RS; Damadzic R; Pilling A; Hamilton JP; Heilig M
    Neuropsychopharmacology; 2017 Aug; 42(9):1789-1799. PubMed ID: 28294133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GABA
    Holtyn AF; Weerts EM
    Curr Top Behav Neurosci; 2022; 52():157-194. PubMed ID: 32808090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The GABA
    Haile CN; Carper BA; Nolen TL; Kosten TA
    Psychopharmacology (Berl); 2021 Sep; 238(9):2587-2600. PubMed ID: 34228136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppressing Effect of Baclofen on Multiple Alcohol-Related Behaviors in Laboratory Animals.
    Colombo G; Gessa GL
    Front Psychiatry; 2018; 9():475. PubMed ID: 30323777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KK-92A, a novel GABA
    Li X; Sturchler E; Kaczanowska K; Cameron M; Finn MG; Griffin P; McDonald P; Markou A
    Psychopharmacology (Berl); 2017 May; 234(9-10):1633-1644. PubMed ID: 28382542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of excessive alcohol drinking by a novel GABAB receptor positive allosteric modulator ADX71441 in mice.
    Hwa LS; Kalinichev M; Haddouk H; Poli S; Miczek KA
    Psychopharmacology (Berl); 2014 Jan; 231(2):333-43. PubMed ID: 23975038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of the GABAB receptor suppressed alcohol self-administration in rats: an effect similar to that produced by GABAB receptor activation.
    Maccioni P; Lorrai I; Carai MAM; Gessa GL; Colombo G
    Behav Pharmacol; 2022 Feb; 33(1):51-60. PubMed ID: 34954712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reducing effect of the novel positive allosteric modulator of the GABA
    Lorrai I; Shankula C; Gaytan JM; Kawamura T; Maccioni P; Mugnaini C; Corelli F; Gessa GL; Sanna PP; Colombo G
    Psychopharmacology (Berl); 2022 Jan; 239(1):201-213. PubMed ID: 34812900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effect of the GABAΒ receptor agonist, baclofen, and the positive allosteric modulator of the GABAB receptor, GS39783, on alcohol self-administration in 3 different lines of alcohol-preferring rats.
    Maccioni P; Zaru A; Loi B; Lobina C; Carai MA; Gessa GL; Capra A; Mugnaini C; Pasquini S; Corelli F; Hyytiä P; Lumeng L; Colombo G
    Alcohol Clin Exp Res; 2012 Oct; 36(10):1748-66. PubMed ID: 22486245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GABAB receptors as a therapeutic strategy in substance use disorders: focus on positive allosteric modulators.
    Filip M; Frankowska M; Sadakierska-Chudy A; Suder A; Szumiec L; Mierzejewski P; Bienkowski P; Przegaliński E; Cryan JF
    Neuropharmacology; 2015 Jan; 88():36-47. PubMed ID: 24971600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo characterization of the novel GABAB receptor positive allosteric modulator, 2-{1-[2-(4-chlorophenyl)-5-methylpyrazolo[1,5-a]pyrimidin-7-yl]-2-piperidinyl}ethanol (CMPPE).
    Perdona' E; Costantini VJ; Tessari M; Martinelli P; Carignani C; Valerio E; Mok MH; Zonzini L; Visentini F; Gianotti M; Gordon L; Rocheville M; Corsi M; Capelli AM
    Neuropharmacology; 2011; 61(5-6):957-66. PubMed ID: 21756923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.